MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis
Cancer Letters · 2026-11 · 660 · 218847
DOI: 10.1016/j.canlet.2026.218847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-11. Verfasst von Shipeng Dai und 18 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medica…. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Lipid Droplets. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Henan Provincial Science and Technology Research Project, Natural Science Foundation of Henan Province, Health Commission of Henan Province.
Abstract (Originalsprache)
Colorectal cancer liver metastasis (CRLM) represents a formidable clinical challenge, yet the metabolic mechanisms by which tumor cells dismantle hepatic immune surveillance and remodel the tumor microenvironment (TME) remain elusive. Here, integrating single-cell RNA sequencing (scRNA-seq), transcriptomic analysis, and mass cytometry (CyTOF), we uncover MAL2 as a key regulator of immune-metabolic crosstalk in CRLM. MAL2 is significantly upregulated and specifically enriched in malignant epithelial cells within liver metastatic lesions. Transcriptomic analysis demonstrates that MAL2 activates non-canonical NF-κB (ncNF-κB) signaling, directly driving FASN transcription, enhancing lipid droplet (LD) biogenesis and secretion, and promoting epithelial-mesenchymal transition (EMT). CyTOF-based immune mapping further indicates that these tumor-derived LDs, upon entering the metastatic microenvironment, selectively recruit PLIN2+ neutrophils and induce neutrophil extracellular traps (NETs), which entrap FABP1+ macrophages and forge an immunosuppressive niche that accelerates metastatic outgrowth. Conceptually, these LDs function as "Trojan horses," appearing as innocuous metabolic gifts while harboring hidden MAL2-driven signals. Once inside the liver, they "open the gates" by recruiting and reprogramming myeloid cells, ultimately dismantling immune defenses from within. Our study establishes MAL2-induced LDs as critical mediators of metastatic immune evasion and nominates the MAL2-ncNF-κB-FASN axis as a therapeutic vulnerability in CRLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation,…
- Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
- Peking Union Medical College Hospital, Department of Liver Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
- Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; Henan Medical Key Laboratory of Tumor Pathology and Artificial Intelligence Diagnosis, Zhengzhou…
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China. Electronic address: liuli@tjutcm.edu.cn.
Förderung
- Henan Provincial Science and Technology Research Project
- Natural Science Foundation of Henan Province
- Health Commission of Henan Province
- Zhengzhou Municipal Science and Technology Bureau
- Nanjing Medical University
- China Postdoctoral Science Foundation
Zitieren
APA
Dai, S., Liu, Z., Sun, J., He, Y., Cao, H., Wang, H., Xie, Y., Huang, T., Chai, Y., Lu, Z., Cheng, P., Xia, Y., Wang, Y., Xia, Q., Wang, X., Xia, Y., Liu, L., Hao, X., & Tang, W. (2026). MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis. Cancer Letters, 660, 218847. https://doi.org/10.1016/j.canlet.2026.218847
Vancouver
Dai S, Liu Z, Sun J, He Y, Cao H, Wang H, et al. MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis. Cancer Letters. 2026;660:218847. doi:10.1016/j.canlet.2026.218847
BibTeX
@article{Dai2026,
author = {Dai, Shipeng and Liu, Ziyuan and Sun, Junjie and He, Yanshu and Cao, Hengsong and Wang, Hongyu and Xie, Yuchen and Huang, Tian and Chai, Yue and Lu, Zhengqing and Cheng, Pengyu and Xia, Yidong and Wang, Yiming and Xia, Qingxin and Wang, Xuehao and Xia, Yongxiang and Liu, Li and Hao, Xiaopei and Tang, Weiwei},
title = {MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis},
journal = {Cancer Letters},
year = {2026},
volume = {660},
pages = {218847},
doi = {10.1016/j.canlet.2026.218847}
}
EUVIMED